Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

Conditions
Malignant Melanoma, Melanoma, Metastatic Melanoma, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer

NCT00100139

Conditions
Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Cancer Institute of New Jersey - University of Medicine and Dentistry of New Jersey New Brunswick, New Jersey, United States
  • Universitatsklinikum Essen Essen, Germany
  • Allgemeines Krankenhaus St. Georg Hamburg, Germany
  • Academisch Medisch Centrum Amsterdam, Netherlands
View Trial Details
Completed

Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer

NCT00080418

Conditions
Neoplasm, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Cancer Institute of New Jersey - University of Medicine and Dentistry of New Jersey New Brunswick, New Jersey, United States
  • Fox Chase Temple Cancer Center - Temple University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

NCT00031278

Conditions
Carcinoma, Carcinoma, Metastatic Breast, Neoplasm Metastasis, +6 more
Locations
  • Univ. of Connecticut Health Center Farmington, Connecticut, United States
  • Cancer Research Network, Inc. Plantation, Florida, United States
  • Greenebaum Cancer Center at Univ. of Maryland Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

NCT00083720

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • ImClone Investigational Site Campbell, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Soquel, California, United States
  • ImClone Investigational Site Jacksonville, Florida, United States
View all 27 locations
View Trial Details

Related conditions